WithdrawnPhase 1NCT03825783

A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Studying Leukocyte adhesion deficiency

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Rocket Pharmaceuticals Inc.
Principal Investigator: Julián Sevilla Navarro, MD, PhD
Hospital Infantil Universitario Niño Jesús (HIUNJ)
Intervention: RP-L201(biological)
Eligibility: All sexes
Timeline: 2019 – 2021

Study locations (1)

Hospital Infantil Universitario Niño Jesús (HIUNJ), Madrid, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03825783 on ClinicalTrials.gov

Other trials for Leukocyte adhesion deficiency

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT06282432
Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
Rocket Pharmaceuticals Inc.

See all trials for Leukocyte adhesion deficiency →

← Back to all trials